RecallDepth
Class II Terminated

Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.

This recall has been terminated (originally issued March 28, 2018).

Company
Teva Pharmaceuticals Usa
Recall Initiated
March 19, 2018
Posted
March 28, 2018
Recall Number
D-0620-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
640,486 vaginal inserts
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

Distribution

Distributed within the United States and Puerto Rico.

Lot / Code Info

Lot #: a) 33812545A, 33812546A, 33812774A, Exp. 12/2018; 33812775A, Exp. 01/2019; 33812776A, 33812777A, Exp. 05/2019; 33813786A, 33813868A, Exp. 7/2019; 33813974A, 33814058A, Exp. 09/2019; 33814113A, Exp. 01/2019; b) 33812547A, 33813361A,33813676A, Exp. 1/2019

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls